Diagnosis and therapy of microscopic colitis with presence of foamy macrophages in children
- PMID: 21991528
- PMCID: PMC3168515
- DOI: 10.5402/2011/756292
Diagnosis and therapy of microscopic colitis with presence of foamy macrophages in children
Abstract
We discuss the diagnosis of and efficacy 5-amino-2-hydroxybenzoic acid (5-ASA), Saccharomyces boulardii, or magnesium in therapy of microscopic colitis with presence of foamy macrophages. A basis for diagnosis and inclusion to the analysed group was presence of characteristic foamy macrophages in histopathological examination of hematoxylin and eosin-stained specimens collected from the large intestine, reviewed under ×200 or ×320 magnification. No statistically significant improvement was found following the use of 5-amino-2-dihydroxybenzoic acid in therapy of the disease. The use of Saccharomyces boulardii was associated with statistically significant improvement in clinical, endoscopic, and histopathological condition. Use of magnesium caused a histological, statistically significant improvement but failed to have any effect on the clinical and endoscopic presentation. In the group of children in whom no therapeutic intervention was provided, a statistically significant spontaneous clinical improvement was observed, but no statistically significant changes in endoscopic and microscopic condition were found.
Figures







Similar articles
-
[Comparative analysis of immunofluorescence double staining for foamy macrophages and Mycobacterium tuberculosis in paraffin-embedded tissue of clinical tuberculous wound].Zhonghua Shao Shang Za Zhi. 2021 Feb 20;37(2):157-163. doi: 10.3760/cma.j.cn501120-20200525-00285. Zhonghua Shao Shang Za Zhi. 2021. PMID: 33498099 Chinese.
-
Effectiveness of Saccharomyces boulardii in a rat model of colitis.World J Gastroenterol. 2012 Nov 28;18(44):6452-60; discussion p. 6459. doi: 10.3748/wjg.v18.i44.6452. World J Gastroenterol. 2012. PMID: 23197891 Free PMC article.
-
Clinical efficacy of Saccharomyces boulardii or metronidazole in symptomatic children with Blastocystis hominis infection.Parasitol Res. 2011 Mar;108(3):541-5. doi: 10.1007/s00436-010-2095-4. Epub 2010 Oct 5. Parasitol Res. 2011. PMID: 20922415 Clinical Trial.
-
Review of Saccharomyces boulardii as a treatment option in IBD.Immunopharmacol Immunotoxicol. 2018 Dec;40(6):465-475. doi: 10.1080/08923973.2018.1469143. Epub 2018 May 17. Immunopharmacol Immunotoxicol. 2018. PMID: 29771163 Review.
-
Histopathological diagnosis of microscopic colitis.J Gastroenterol Hepatol. 2006 May;21(5):792-7. doi: 10.1111/j.1440-1746.2006.04332.x. J Gastroenterol Hepatol. 2006. PMID: 16704525 Review.
Cited by
-
Cancer-associated foam cells hamper protective T cell immunity and favor tumor progression in human colon carcinogenesis.J Immunother Cancer. 2024 Oct 12;12(10):e009720. doi: 10.1136/jitc-2024-009720. J Immunother Cancer. 2024. PMID: 39395839 Free PMC article.
References
-
- Librecht L, Croes R, Ectors N. Microscopic colitis with giant cells. Histopatology. 2006;48:116–132. - PubMed
-
- Yantiss RK, Odze RD. Diagnostic difficulties in inflammatory bowel disease pathology. Histopathology. 2006;48(2):116–132. - PubMed
-
- Warren BF, Edwards CM, Travis SPL. Microscopic colitis, classification and terminology. Histopathology. 2002;40(4):374–376. - PubMed
-
- Józefczuk J, Woźniewicz B, Romańczuk W. Patologia i klinika nowej formy zapalenia jelita grubego u dzieci. Pediatria Współczesna. Gastroenterologia, Hepatologia i Żywienie Dziecka. 2003;5(3):151–156.
-
- Józefczuk J, Woźniewicz B, Romańczuk W. Clinico-pathology of Foamy Cell Colitis (FCC), the new form non-inflamatory bowel disease. Annals of Diagnostic Paediatric Pathology. 2001;5:71–74.
LinkOut - more resources
Full Text Sources